Invesco
TARA icon

Invesco’s Protara Therapeutics TARA Stock Holding History

Invesco’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$93.6K Buy
17,961
+447
+3% +$2.65K ﹤0.01% 3633
2025
Q4 		$93.3K Sell
17,514
-7,655
-30% -$42.6K ﹤0.01% 3645
2025
Q3 		$109K Buy
25,169
+1,234
+5% +$4K ﹤0.01% 3673
2025
Q2 		$72.5K Buy
+23,935
New +$82.6K ﹤0.01% 3690
2015
Q3 		– Sell
-9
Closed -$6K – 3976
2015
Q2 		$6K Buy
+9
New +$5.57K ﹤0.01% 4135

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Invesco's TARA Position: Q1 2026 in Review

Invesco increased its Protara Therapeutics (TARA) stake by 2.6% in Q1 2026, buying an estimated $2.65K and bringing the position to 17,961 shares worth $93.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3633.

Invesco first reported a position in TARA in Q2 2015 and has held it in 5 quarters since. The position peaked at $109K in Q3 2025. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • Invesco held 17,961 shares of Protara Therapeutics worth $93.6K as of Q1 2026.
  • Invesco bought 447 Protara Therapeutics shares in Q1 2026, an estimated $2.65K.
  • Protara Therapeutics made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3633 holding.
  • Invesco first reported a position in Protara Therapeutics in Q2 2015 and has held it in 5 quarters since.
  • Invesco's Protara Therapeutics position peaked at $109K in Q3 2025.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.